Literatur
Ginsberg RJ, Rubinstein LV, Lung Cancer Study Group. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Ann Thorac Surg. 1995;60:615-23
Saji H, Okada M, Tsuboi M et al. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial. Lancet. 2022;399:1607-17
Altorki NK, Wang X, Wigle D et al. Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503). Lancet Respir Med. 2018;6:915-24
Kohman LJ, Gu L, Altorki et al. Biopsy first: lessons learned from cancer and leukemia group B (CALGB) 140503. J Thorac Cardiovasc Surg. 2017;153:1592-7
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gillissen, A. Resektion im Stadium IA: Wie viel reicht aus?. Pneumo News 15, 16–17 (2023). https://doi.org/10.1007/s15033-023-3480-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15033-023-3480-x